DEPDC1-AS1: A Potential Drug Target and Biomarker (G101927220)

Target Name: DEPDC1-AS1

NCBI ID: G101927220

DEPDC1-AS1

Other Name(s): DEPDC1 antisense RNA 1

DEPDC1-AS1: A Potential Drug Target and Biomarker

DEPDC1-AS1, a novel RNA molecule, has been identified as a potential drug target and biomarker for various diseases. DEPDC1 is a gene that encodes a protein involved in the development and progression of cancer, while AS1 encodes an antisense RNA. The expression of DEPDC1 and AS1 has been shown to be reduced in various types of cancer, suggesting that they may play a crucial role in the development and progression of these diseases.

DEPDC1-AS1: A Putative Drug Target

The identification of DEPDC1-AS1 as a potential drug target is based on several lines of evidence. First, DEPDC1 has been shown to be involved in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancers. Second, studies have shown that inhibition of DEPDC1 has led to a reduction in the growth and spread of cancer cells. Third, overexpression of AS1 has been shown to enhance the sensitivity of cancer cells to chemotherapy and radiation treatment.

These findings suggest that DEPDC1 and AS1 may be useful targets for cancer treatment. By inhibiting the activity of DEPDC1, researchers may be able to reduce the growth and spread of cancer cells and improve the overall effectiveness of cancer treatments.

DEPDC1-AS1: A Potential Biomarker

In addition to its potential as a drug target, DEPDC1-AS1 may also be a useful biomarker for various types of cancer. The reduced expression of DEPDC1 and AS1 in cancer cells may be an indicator of the disease, allowing for the early detection and diagnosis of cancer.

Furthermore, DEPDC1-AS1 has been shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancers. This suggests that it may be a useful biomarker for these specific types of cancer.

Conclusion

In conclusion, DEPDC1-AS1 is a novel RNA molecule that has been identified as a potential drug target and biomarker for various types of cancer. Its expression reduction in cancer cells and its potential as a drug target make it an attractive target for cancer research and treatment. Further studies are needed to fully understand the role of DEPDC1-AS1 in cancer development and progression.

Protein Name: DEPDC1 Antisense RNA 1

The "DEPDC1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DEPDC1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets